A 40-week, dose-finding study to examine the safety, effectiveness and how the body interacts with administered substances for the entire duration of the study. The study will be a double-blinded, placebo-controlled study injecting subcutaneously (under the skin) once a week, along with a reduced-calorie diet and increased physical activity in participants with obesity.